LEXINGTON, Mass.--(BUSINESS WIRE)--Acusphere, Inc. (ACUS.PK) today issued the following letter to shareholders:
Dear Fellow Shareholders:
We have been working diligently to support continued development of our lead product candidate, Imagify™ (Perflubutane Polymer Microspheres) for Injectable Suspension. We have now arrived at an important juncture, and we need your support to help effect a reverse stock split to allow the Company to finance the completion of our strategic direction.
